Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to -$158.3 million.

  • Assembly Biosciences' Cash from Investing Activities fell 74632.06% to -$158.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$141.4 million, marking a year-over-year decrease of 23044.38%. This contributed to the annual value of $40.2 million for FY2024, which is 15810.26% up from last year.
  • Latest data reveals that Assembly Biosciences reported Cash from Investing Activities of -$158.3 million as of Q3 2025, which was down 74632.06% from $17.0 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Cash from Investing Activities peaked at $33.0 million during Q1 2022, and registered a low of -$158.3 million during Q3 2025.
  • In the last 5 years, Assembly Biosciences' Cash from Investing Activities had a median value of $10.0 million in 2023 and averaged -$2.4 million.
  • Per our database at Business Quant, Assembly Biosciences' Cash from Investing Activities surged by 41088.44% in 2022 and then crashed by 74632.06% in 2025.
  • Over the past 5 years, Assembly Biosciences' Cash from Investing Activities (Quarter) stood at -$8.5 million in 2021, then soared by 295.21% to $16.6 million in 2022, then plummeted by 641.32% to -$89.7 million in 2023, then soared by 92.53% to -$6.7 million in 2024, then tumbled by 2263.66% to -$158.3 million in 2025.
  • Its Cash from Investing Activities stands at -$158.3 million for Q3 2025, versus $17.0 million for Q2 2025 and $6.6 million for Q1 2025.